Can Consumers and Audiologists Detect Ear Disease Prior to Hearing Aid use?

Overview

About this study

The purpose of this study is to determine if lay persons and non-physician hearing healthcare providers (e.g. audiologists) can detect ear disease using focused questionnaires (Consumer Ear Disease Risk Assessment [CEDRA] & audiologist based Ear Disease Risk Assessment tool [PEDRA])? The overarching goal of this work is to decrease the cost and increase accessibility of hearing aids and related hearing healthcare services while protecting consumers from the consequences of unrecognized ear disease. In so doing, we will also decrease the cost burden to the overall healthcare system by encouraging only those consumers with high risk of ear disease to seek medical services rather than the current model that encourages all consumers with age related hearing loss to receive medical clearance prior to hearing aid purchase.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

A new or old patient who present to the department of Otorhinolaryngology/Audiology with ear or hearing complaints.
A new or old patient seeking hearing aids.

Exclusion Criteria:

Age under 40 or over 80 years.
Unwillingness or inability to complete paper and pencil questionnaire.
Already receiving care for a known ear or hearing problem.

More information

Publications

Publications are currently not available

Clinical Trials